Abstract:Growing evidence indicates that iron overload is an independent risk factor for osteoporosis. However, the mechanisms are not fully understood. The purpose of our study was to determine whether iron overload could lead to ferroptosis in osteoblasts and to explore whether ferroptosis of osteoblasts is involved in iron overload‐induced osteoporosis in vitro and in vivo. Ferric ammonium citrate was used to mimic iron overload conditions, while deferoxamine and ferrostatin‐1 were used to inhibit ferroptosis of MC3T3‐E1 cells in vitro. The ferroptosis, osteogenic differentiation and mineralization of MC3T3‐E1 cells were assessed in vitro. A mouse iron overload model was established using iron dextran. Immunohistochemical analysis was performed to determine ferroptosis of osteoblasts in vivo. Enzyme‐linked immunosorbent assays and calcein–alizarin red S labelling were used to assess new bone formation. Dual X‐ray absorptiometry, micro‐computed tomography and histopathological analysis were conducted to evaluate osteoporosis. The results showed that iron overload reduced cell viability, superoxide dismutase and glutathione levels, increased reactive oxygen species generation, lipid peroxidation, malondialdehyde levels and ferroptosis‐related protein expression, and induced ultrastructural changes in mitochondria. Iron overload could also inhibit osteogenic differentiation and mineralization in vitro. Inhibiting ferroptosis reversed the changes described above. Iron overload inhibited osteogenesis, promoted the ferroptosis of osteoblasts and induced osteoporosis in vivo, which could also be improved by deferoxamine and ferrostatin‐1. These results demonstrate that ferroptosis of osteoblasts plays a crucial role in iron overload‐induced osteoporosis. Maintaining iron homeostasis and targeting ferroptosis of osteoblasts might be potential measures of treating or preventing iron overload‐induced osteoporosis. This article is protected by copyright. All rights reserved.

Effects of the ferroptosis inducer erastin on osteogenic differentiation and biological pathways of primary osteoblasts

Unraveling ferroptosis in osteogenic lineages: implications for dysregulated bone remodeling during periodontitis progression

Ferritin was involved in interleukin-17A enhanced osteogenesis through autophagy activation

Targeting Ferroptosis in Breast Cancer

Ferroptosis: A New Regulatory Mechanism in Osteoporosis

Ferroptosis: A New Development Trend in Periodontitis

Ebselen restores peri-implantitis-induced osteogenic inhibition via suppressing BMSCs ferroptosis

Interleukin-17 alleviates erastin-induced alveolar bone loss by suppressing ferroptosis via interaction between NRF2 and p-STAT3.

Fibroblast Ferroptosis is Involved in Periodontitis-Induced Tissue Damage and Bone Loss

Overburdened Ferroptotic Stress Impairs Tooth Morphogenesis

Molecular mechanisms of ferroptosis and its role in cancer therapy

Bone Formation Ability and Cell Viability Enhancement of MC3T3-E1 Cells by Ferrostatin-1 a Ferroptosis Inhibitor of Cancer Cells

Ferroptosis - A new target of osteoporosis

Exploring the molecular mechanisms of ferroptosis-related genes in periodontitis: a multi-dataset analysis

Ferroptosis in Osteocytes as a Target for Protection Against Postmenopausal Osteoporosis

Research Progress of Ferroptosis Regulatory Network and Bone Remodeling in Osteoporosis.

Ferroptosis and Its Implications in Bone-Related Diseases

Iron overload‐induced ferroptosis of osteoblasts inhibits osteogenesis and promotes osteoporosis: an in vitro and in vivo study

An update on the role of ferroptosis in the pathogenesis of osteoporosis

Role of ferroptosis in Porphyromonas gingivalis-induced impairment of epithelial junction

Screening diagnostic markers of osteoporosis based on ferroptosis of osteoblast and osteoclast